Lancet Global Health

Article	Citations
Global health research funding applications: brain drain under another name?	771
Bringing home manufacturing of medical products	747
Queering global health: a feminist and lesbian, gay, and bisexual perspective – Authors' reply	312
Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income cou	312
Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical m	271
Influenza vaccination in failing hearts	270
The future of the International Health Regulations	260
The health status of Indonesia's provinces: the double burden of diseases and inequality gap	259
Implementation of dual maternal HIV-Syphilis testing: The devil is in the details	224
C-reactive protein: another addition to our armamentarium against tuberculosis?	222
Periconceptional diet and the risk of gestational diabetes in south Indian women: findings from the BAngalore Nutrition Gestational diabetes LiFEstyle Study (BANGLES)	206
Preventing pellagra during isoniazid preventive treatment	201
Comparison of maternal and neonatal outcomes of COVID-19 before and after SARS-CoV-2 omicron emergence in maternity facilities in Malawi (MATSurvey): data from a national maternal surveillance platfor	194
Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled tr	191
Correction to Lancet Glob Health 2024; published online Sept 23. https://doi.org/10.1016/S2214-109X(24)00320-6	177
Correction to Lancet Glob Health 2021; 9: e1679–87	174
Correction to Lancet Glob Health 2021; 9: e908–09	172
Challenges in operationalising clinical trials in India during the COVID-19 pandemic	159
The cause of nodding syndrome remains unknown	159
Outcomes of rheumatic fever in Uganda: a prospective cohort study	150
Racism and health: the need for urgent action	149
Global and regional sepsis and infectious syndrome mortality in 2019: a systematic analysis	148
Indonesia's first nationwide health screening programme	139
Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study	135
Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys	134

COVID-19 pandemic and health-care disruptions: count the most vulnerable	130
Implementation of the 7-1-7 target for detection, notification, and response to public health threats in five countries: a retrospective, observational study	126
Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study	126
Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: a phase 3b, prospective, open-label, non-randomised, cohort study	126
Automated oxygen control for preterm infants receiving continuous positive airway pressure in southwest Nigeria: an open-label, randomised, crossover trial	125
Mpox vaccination strategies in DR Congo	121
Global patterns and trends in Kaposi sarcoma incidence: a population-based study	120
Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial	120
Resolving the CD4-testing crisis to help end AIDS-related deaths	119
Assessing the prevalence and impact of preserved ratio impaired spirometry in low-income and middle-income countries: a post-hoc cross-sectional analysis	119
Mortality in patients admitted to hospital with heart failure in China: a nationwide Cardiovascular Association Database-Heart Failure Centre Registry cohort study	116
Prenatal exposure to HIV pre-exposure prophylaxis and birth, growth, and social–emotional developmental outcomes throughout early childhood in Kenya: a prospective cohort study	115
Is now the time for revisiting supplements for pregnant women?	115
Challenges in interpreting SARS-CoV-2 serological results in African countries	111
Patient-level and system-level determinants of stroke fatality across 16 large hospitals in Ghana and Nigeria: a prospective cohort study	109
The drug drought in maternal health: an ongoing predicament	106
The state of health in Pakistan and its provinces and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019	101
Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis	101
Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial	96
The cost of inaction on physical inactivity to public health-care systems: a population-attributable fraction analysis	96
WHO model list of essential in vitro diagnostics: strengthening diagnostics capacity to transform health care for all	94
Next generation economics of universal HIV treatment	93
Locally validated biomarker cutoffs should inform micronutrient deficiency burdens – Authors' reply	93
Pregnancy, pregnancy outcomes, and infant growth and development after recovery from Ebola virus disease in Liberia: an observational cohort study	92
Addressing the complex needs of people with severe mental health disorders in low-resource settings	91
Mpox: evidence for strengthening and sustaining global surveillance	91
Achieving sensible targets for a diabetes care cascade in LMICs	89
Commitment and innovation on the road to people-centred PHC financing	89
Pregnancy in people who have survived Ebola virus disease	88
From child institutions to family reunification: challenges and opportunities in building family-centred care	87
Child, maternal, and adult mortality in Sierra Leone: nationally representative mortality survey 2018–20	85
Advancing maternal and perinatal health through clinical trials: key insights from a WHO global consultation	84
Understanding deaths from diarrhoea in children younger than 5 years	83
Innovative blood transfusion strategies to address global blood deserts: a consensus statement from the Blood Delivery via Emerging Strategies for Emergency Remote Transfusion (Blood DESERT) Coalition	83
A call for an Africa-centric health research ethics framework: a way forward for shaping global health research	81
Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study	80
Cervical cancer elimination: actions needed in the COVID-19 era	80
Aedes albopictus invasion across Africa: the time is now for cross-country collaboration and control	79
Resetting the agenda for antibiotic resistance through a health systems perspective	79
COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns	79
The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review	79
Cholera rapid diagnostic tests recycled for PCR confirmation	78
Using theory to understand how interventions work and inform future implementation	77
Reducing global inequities in medical oxygen access: the Lancet Global Health Commission on medical oxygen security	77
Lessons for future implementation of the E-MOTIVE bundle	76
Payment in arrears: a global health inequity that must be corrected	75
Introduction and rollout of malaria vaccines in Cameroon and Burkina Faso: early lessons learned	75
Improving access to liposomal amphotericin B worldwide	74
Impact of excluded studies on medical male circumcision and HIV risk compensation	73
The social determinants of tuberculosis in the Philippines	72

Mathematical modelling to accurately quantify the benefits of pneumococcal conjugate vaccine	71
Policy prioritisation to address the global burden of rheumatic heart disease	71
Experiences of an Israeli hospital in the management of repatriated civilian hostages	70
Bridging the gap between science and policy in global health governance	68
Using verbal autopsy to enhance mortality surveillance	66
Correction to Lancet Glob Health 2023; 11: e1978–85	64
Correction to Lancet Glob Health 2022; 10: e1443–52	64
Complementary medicine as a risk factor for catastrophic expenditures in people with cancer	63
Staying focused on protecting young people from the harms of tobacco smoke	63
Highlighting the need for investment and innovation in ART retention interventions	63
How to DREAMM and end HIV-related deaths	62
Quality of inpatient paediatric and newborn care in district hospitals: WHO indicators, measurement, and improvement	61
TAK-003 dengue vaccine as a new tool to mitigate dengue in countries with a high disease burden	60
Catastrophic health expenditure during the COVID-19 pandemic in five countries: a time-series analysis	60
Sustainability of a 12-month lifestyle intervention delivered by community health workers in reducing blood pressure in Nepal: 5-year follow-up of the COBIN open-label, cluster randomised trial	60
Addressing the social inequities of vaccination: an imperative to close the gap	60
Uncertainty in key population size estimates in sub-Saharan Africa	60
Infertility—why the silence?	60
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026	59
Role of community-based cohorts for uncovering the iceberg of disease	57
Correction to Lancet Glob Health 2022; 10: e1115–27	56
Precision in prescription: multiple micronutrient supplements in pregnancy	56
Implementation strategies to build mental health-care capacity in Malawi: a health-economic evaluation	56
Implications of critical race theory for Aboriginal and Torres Strait Islander men's health	56
Addressing global micronutrient inadequacies: enhancing global data representation	55
Migrants and displaced people: intentionally endangered and inconsistently visible	54
Lots of considerations when evaluating the FujiLAM assay – Author's reply	54
Withholding liberty, not the right to health	54
People who inject drugs in the Eastern Mediterranean region	54
Hepatitis E vaccination: continued benefit for pregnant women in vulnerable settings	53
The impact of ivermectin, diethylcarbamazine citrate, and albendazole mass drug administration on the prevalence of scabies and soil-transmitted helminths in school-aged children in three municipaliti	51
Maternal intimate partner violence and child health outcomes	51
COVID-19 in pregnancy: evidence from LMICs	51
Respiratory syncytial virus infection among children younger than 2 years admitted to a paediatric intensive care unit with extended severe acute respiratory infection in ten Gavi-eligible countries:	49
The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis	49
Pulse oximetry to detect paediatric hypoxaemia—the fifth vital sign	48
Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis	48
Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b–2a, double-blind, dose-escalation, randomised controlled t	48
Every baby counts: eliminating all preventable child deaths	48
Keeping an eye on eye care: monitoring progress towards effective coverage	47
Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study	47
Characterisation of febrile non-traumatic coma in sub-Saharan Africa	46
Unveiling the crisis of the double burden of malnutrition	46
Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data	45
The landscape for rare diseases in 2024	45
Reducing antibiotic use with diarrhoeal vaccines	44
COVID-19 intra-action reviews: potential for a sustained response plan	44
Family-based approach in cardiovascular risk reduction	44
Equity challenges in Indonesian health care	44
Reciprocal innovation: a new approach to equitable and mutually beneficial global health research and partnerships	44
Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive Heart Failure (G-CHF) regi	43
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Le	43
Innovative methods of determining health expenditure efficiency are urgently needed	43
Impact of excluded studies on medical male circumcision and HIV risk compensation – Authors' reply	43
Cost-effectiveness of the expansion of PrEP for HIV infection in the Asia Pacific region	42
Insights from Zimbabwe's SARS-CoV-2 genomic surveillance	42
The incalculable costs of tuberculosis	41
Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines	41
Tuberculosis and undernutrition in India – Authors’ reply	41
Geospatial disparities in survival of patients with breast cancer in sub-Saharan Africa from the African Breast Cancer-Disparities in Outcomes cohort (ABC-DO): a prospective cohort study	40
Predicting mortality within 1 year of ART initiation in children and adolescents living with HIV in sub-Saharan Africa: a retrospective observational cohort study	40
Can resistance testing improve outcomes for children and adolescents with HIV?	40
Maximising human health and development through synergistic partnerships: the African Biobank and Longitudinal Epidemiological Ecosystem	39
Can the ShangRing bring us closer to endorsing early infant male circumcision in sub-Saharan Africa?	39
The challenge of promoting physical activity in low-income and middle-income countries	39
More treatment options for rifampicin-resistant tuberculosis: the role of economic evaluation in informing uptake	39
Preparing for COVID-19 vaccine roll-out through simulation exercises	39
Correction to Lancet Glob Health 2020; 8: e1186–94	38
Correction to Lancet Glob Health 2024; 12: e1389–90	38
Universal health coverage is fundamental to preparing for a healthier and better tomorrow	38
Incidence of and risk factors for small vulnerable newborns in north India: a secondary analysis of a prospective pregnancy cohort	38
Estimating the cost of achieving basic water, sanitation, hygiene, and waste management services in public health-care facilities in the 46 UN designated least-developed countries: a modelling study	37
Avoiding another lost decade in reducing malaria burden in African infants and young children	37
Pesticide surveillance and deaths by suicide	37
Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: a prospective cohort study	36
Policy and service delivery proposals to improve primary care services in low-income and middle-income country cities	36
Homing in on haemoglobinopathies	36
Donor aid and research funding for newborn babies and preventing stillbirths	36
Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries	36
Infant-level and child-level predictors of mortality in low-resource settings: the WHO Child Mortality Risk Stratification Multi-Country Pooled Cohort	36

Prices, availability, and affordability of adult medicines in 54 low-income and middle-income countries: evidence based on a secondary analysis	36
Convergence of infectious and non-communicable disease epidemics in rural South Africa: a cross-sectional, population-based multimorbidity study	36
The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries	35
Nutritional support for adult patients with microbiologically confirmed pulmonary tuberculosis: outcomes in a programmatic cohort nested within the RATIONS trial in Jharkhand, India	35
Wastewater monitoring can anchor global disease surveillance systems	35
Prevalence of syphilis among men who have sex with men: a global systematic review and meta-analysis from 2000–20	35
Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories	35
How the EAT–Lancet Commission on food in the Anthropocene influenced discourse and research on food systems: a systematic review covering the first 2 years post-publication	34
Uncertainty in computerised analysis of maternal deaths	34
Social and health factors associated with adverse treatment outcomes among people with multidrug-resistant tuberculosis in Sierra Leone: a national, retrospective cohort study	34
Climate change and the right to health of people with disabilities	34
Azithromycin for the prevention of rehospitalisation and death among Kenyan children being discharged from hospital: a double-blind, placebo-controlled, randomised controlled trial	33
Moving beyond standard RMNCH coverage indicators	33
Combating antimicrobial resistance in neonatal infections: a South African perspective	33
Finding balance in Nigeria's mandatory health insurance	33
Colorectal cancer screening with fecal immunochemical testing in Nigeria – Authors' reply	33
Pragmatic global health	32
Enhancing cervical and breast cancer training in Africa with e-learning	32
Aminoglycosides, deafness, and non-tuberculous mycobacteria	32
Global variations in barriers to exercise for individuals with intellectual and developmental disability	31
Defining the usefulness of oral swabs in tuberculosis diagnosis	31
Challenges of adopting new trial designs in LMICs	31
Navigating AMR with innovative diagnostics	31
Correction to Lancet Glob Health 2022; 10: 1715–43	31
Prevention of pneumococcal diseases: the challenge remains	31
Postnatal morbidity: prevalent, enduring, and neglected	31
Trans Reform: an initiative for the recognition of transgender rights in a university in Lima, Peru	31
Nodding syndrome and doxycycline: promising findings with open questions	30
The SARS-CoV2 pandemic and routine immunisation	30
The challenging road to universal health coverage	30
Questions about the HELIX trial	30
The need for a One Health approach for influenza surveillance	30
National diabetes prevention programmes in LMICs are now a necessity	30
Balancing global access to opioids	30
Relapse after recovery from acute malnutrition	30
Neonatal mortality during the war in Tigray: a cross-sectional community-based study	30
Primary care institutional characteristics associated with hypertension awareness, treatment, and control in the China PEACE-Million Persons Project and primary health-care survey: a cross-sectional s	29
Targeting malaria control to schoolchildren	29
Implementation of non-communicable disease policies from 2015 to 2020: a geopolitical analysis of 194 countries	29
Global radiotherapy demands and corresponding radiotherapy-professional workforce requirements in 2022 and predicted to 2050: a population-based study	29
Colorectal cancer screening in sub-Saharan Africa	29
Ethical considerations for introducing RTS,S/AS01 in countries with moderate to high Plasmodium falciparum malaria transmission	29
The effect of a social network-based intervention to promote HIV testing and linkage to HIV services among fishermen in Kenya: a cluster-randomised trial	29
Correction to Lancet Glob Health 2025; 13: e528–84	28
Correction to Lancet Glob Health 2025; 13: e309–18	28
Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial	28
Enabling access to quality abortion care: WHO's Abortion Care guideline	28
Efficacy of a family-based cardiovascular risk reduction intervention in individuals with a family history of premature coronary heart disease in India (PROLIFIC): an open-label, single-centre, cluste	28
Global retinoblastoma survival and globe preservation: a systematic review and meta-analysis of associations with socioeconomic and health-care factors	28
Mpox vaccination strategies in DR Congo	27
Variability and social patterning of cancer mortality in 343 Latin American cities: an ecological study	27
Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study	27
Distinguishing between mortality rates for heart failure with preserved versus reduced ejection fraction – Authors' reply	27
Scarcity of research on breastfeeding and Ebola diseases is placing the lives of women and infants at risk: a call to specific action	27
The need for epidemiological data on HIV-related CNS infections in low-income and middle-income settings	27
The continuum of menstrual health through the life course	27
The effect on HIV transmission and cost-effectiveness of programmes for female sex workers in East, Central, and Southern Africa: a modelling study	26
Diagnostic yield as an important metric for the evaluation of novel tuberculosis tests: rationale and guidance for future research	26
Global, regional, and national causes of death in children and adolescents younger than 20 years: an open data portal with estimates for 2000–21	26
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial	26
Are current systems of global health academia fit for purpose?	26
Correction to Lancet Glob Health 2021; 9: e366–71	25
The impact of COVID-19 on antimalarial supply chains in Ghana	25
Obstetric fistula in Bangladesh: estimates from a national survey with clinical validation correction	25
Peripheral artery disease: a global need for detection, prevention, and treatment	25
Clearing our heads over alcohol	25
Postpartum maternal and infant haematological effects of second-trimester ferric carboxymaltose versus standard-of-care oral iron in Malawi: longitudinal follow-up of a randomised controlled trial	25
Correction to Lancet Glob Health 2021; 9: e1610–17	25
Short-term aid or long-term gains? Harnessing Sudan's humanitarian response for the resilience of its health system	25
Correction to Lancet Glob Health 2024; 12: e1209–13	25
Where are the opportunities to address system barriers preventing equitable cardiovascular outcomes for indigenous populations?	25
Correction to Lancet Glob Health 2024; 12: e25–27	25
Indigenous and minority groups in diabetes trials	25
Current testing systems are a barrier to achieving the 7-1-7 target for detection, notification, and response to public health threats	25
Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models	25
Strengthening health-care systems to reduce child mortality	25
Cost-effectiveness of intervention combinations towards the elimination of vertical transmission of HIV in limited-resource settings: a mathematical modelling study	24
Low-value health care in the COVID-19 pandemic	24
Population size, HIV prevalence, and antiretroviral therapy coverage among key populations in sub-Saharan Africa: collation and synthesis of survey data, 2010–23	24
Effectiveness of a new vaccine for outbreak response and the increasingly complicated polio endgame	24
Research ethics systems in Latin America and the Caribbean: a systemic assessment using indicators	24
Bridging the divide between religion and health care	24
The use of imagery in global health: an analysis of infectious disease documents and a framework to guide practice	24
Exposure to household air pollution from cooking fuel in Ugandan households and associated household factors: a retrospective analysis of demographic and health survey data	24
Democratising clinical trials research to strengthen primary health care	24
Social determinants of mental health and the COVID-19 pandemic in low-income and middle-income countries	24
What can we learn from developments in primary health care in south Asia?	24
Maximising the value of nudge units for global health	24
Redefining implementation science for global health decolonisation	24
Nigeria's mandatory health insurance and the march towards universal health coverage	23
Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey	23
Randomised trials at the level of the individual	23
Why and for whom are we decolonising global health?	23
Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance	23
A call to action: the global failure to effectively tackle maternal mortality rates	23